Charles B. Smith - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Monoamines, opioids, drugs of abuse
Website:
http://sitemaker.umich.edu/smith/home

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1996 Cameron OG, Smith CB, Nesse RM, Hill EM, Hollingsworth PJ, Abelson JA, Hariharan M, Curtis GC. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives. Psychosomatic Medicine. 58: 289-301. PMID 8827791 DOI: 10.1097/00006842-199607000-00001  0.312
1995 Yoshioka M, Matsumoto M, Numazawa R, Togashi H, Smith CB, Saito H. Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment. European Journal of Pharmacology. 294: 565-70. PMID 8750719 DOI: 10.1016/0014-2999(95)00582-X  0.328
1994 Matsumoto M, Yoshioka M, Togashi H, Hirokami M, Tochihara M, Ikeda T, Smith CB, Saito H. mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis. Brain Research. 636: 1-8. PMID 8156397 DOI: 10.1016/0006-8993(94)90169-4  0.305
1992 Yoshioka M, Matsumoto M, Togashi H, Smith CB, Saito H. Effect of clonidine on the release of serotonin from the rat hippocampus as measured by microdialysis. Neuroscience Letters. 139: 57-60. PMID 1383883 DOI: 10.1016/0304-3940(92)90857-4  0.307
1992 Yoshioka M, Matsumoto M, Togashi H, Smith CB, Saito H. Alpha 2-adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neuroscience Letters. 139: 53-6. PMID 1357604 DOI: 10.1016/0304-3940(92)90856-3  0.331
1991 Weishaar RE, Webb RC, Smith CB. Changes in alpha 2-adrenoceptors on vascular smooth muscle and neural membranes following hypertension induced by renal ischemia. Pharmacology. 43: 187-98. PMID 1685246 DOI: 10.1159/000138845  0.336
1991 Heyl DL, Omnaas JR, Sobczyk-Kojiro K, Medzihradsky F, Smith CB, Mosberg HI. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide. International Journal of Peptide and Protein Research. 37: 224-9. PMID 1651290 DOI: 10.1111/J.1399-3011.1991.Tb00274.X  0.309
1990 Haaseth RC, Sobczyk-Kojiro K, Medzihradsky F, Smith CB, Mosberg HI. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features. International Journal of Peptide and Protein Research. 36: 139-46. PMID 2177042 DOI: 10.1111/J.1399-3011.1990.Tb00957.X  0.313
1990 Cameron OG, Smith CB, Lee MA, Hollingsworth PJ, Hill EM, Curtis GC. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Biological Psychiatry. 28: 3-20. PMID 2165422 DOI: 10.1016/0006-3223(90)90427-4  0.305
1990 Grunhaus LJ, Cameron O, Pande AC, Haskett RF, Hollingsworth PJ, Smith CB. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors. Acta Psychiatrica Scandinavica. 81: 216-9. PMID 2160772 DOI: 10.1111/J.1600-0447.1990.Tb06483.X  0.313
1989 Hollingsworth PJ, Smith CB. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain. European Journal of Pharmacology. 168: 159-67. PMID 2558024 DOI: 10.1016/0014-2999(89)90561-X  0.356
1989 Smith CB, Moises HC, Spengler RN, Hollingsworth PJ. Changes in alpha 2-adrenoceptor number and function in brains of morphine-dependent rats. European Journal of Pharmacology. 161: 111-9. PMID 2542041 DOI: 10.1016/0014-2999(89)90833-9  0.379
1989 Grunhaus L, Tiongco D, Zelnik T, Flegel P, Hollingsworth PJ, Smith CB. Intravenous yohimbine. Selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humans. Clinical Neuropharmacology. 12: 106-14. PMID 2541903 DOI: 10.1097/00002826-198904000-00004  0.3
1989 Moises HC, Smith CB. Electrophysiological responsiveness to isoproterenol in rat hippocampal slices correlates with changes in beta-adrenergic receptor density induced by chronic morphine treatment. Brain Research. 485: 67-78. PMID 2541865 DOI: 10.1016/0006-8993(89)90667-7  0.34
1988 Mosberg HI, Omnaas JR, Medzihradsky F, Smith CB. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity. Life Sciences. 43: 1013-20. PMID 2845204 DOI: 10.1016/0024-3205(88)90547-4  0.303
1987 Moises HC, Smith CB. Changes in cortical beta-adrenergic receptor density and neuronal sensitivity to norepinephrine accompany morphine dependence and withdrawal. Brain Research. 400: 110-26. PMID 3028564 DOI: 10.1016/0006-8993(87)90658-5  0.329
1986 Lessor RA, Bajwa BS, Rice KC, Jacobson AE, Streaty RA, Klee WA, Smith CB, Aceto MD, May EL, Harris LS. Probes for narcotic receptor mediated phenomena. 13. Potential irreversible narcotic antagonist-based ligands derived from 6,14-endo-ethenotetrahydronororipavine with 7-(methoxyfumaroyl)amino, (bromoacetyl)amino, or isothiocyanate electrophiles: chemistry, biochemistry, and pharmacology. Journal of Medicinal Chemistry. 29: 2136-41. PMID 3023609 DOI: 10.1021/Jm00161A002  0.301
1985 Aceto MD, Harris LS, Woods JH, Katz JL, Smith CB, Medzihradsky F, Jacobson AE, Shiotani S. Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans). Japanese Journal of Pharmacology. 39: 7-19. PMID 4068392 DOI: 10.1254/Jjp.39.7  0.317
1985 Silverstein F, Smith CB, Johnston MV. Effect of clonidine on platelet alpha 2-adrenoreceptors and plasma norepinephrine of children with Tourette syndrome. Developmental Medicine and Child Neurology. 27: 793-9. PMID 3005096 DOI: 10.1111/J.1469-8749.1985.Tb03804.X  0.365
1985 Rosen J, Silk KR, Rice HE, Smith CB. Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study. Biological Psychiatry. 20: 539-45. PMID 2985130 DOI: 10.1016/0006-3223(85)90025-3  0.346
1984 Moises HC, Smith CB. Changes occur in central adrenoreceptor function following long-term morphine treatment and during morphine withdrawal. Neuropeptides. 5: 29-32. PMID 6152326 DOI: 10.1016/0143-4179(84)90019-2  0.318
1984 Smith CB, Bennett-Kelly L, Woods JH. Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens. Neuropeptides. 5: 161-4. PMID 6099488 DOI: 10.1016/0143-4179(84)90052-0  0.301
1984 Weiss RJ, Webb RC, Smith CB. Comparison of alpha 2 adrenoreceptors on arterial smooth muscle and brain homogenates from spontaneously hypertensive and Wistar-Kyoto normotensive rats. Journal of Hypertension. 2: 249-55. PMID 6099386 DOI: 10.1097/00004872-198406000-00005  0.34
1984 Cameron OG, Smith CB, Hollingsworth PJ, Nesse RM, Curtis GC. Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety. Archives of General Psychiatry. 41: 1144-8. PMID 6095785 DOI: 10.1001/Archpsyc.1984.01790230030004  0.326
1984 Rice HE, Smith CB, Silk KR, Rosen J. Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment. Psychiatry Research. 12: 69-77. PMID 6087398 DOI: 10.1016/0165-1781(84)90139-2  0.369
1983 Smith CB, Hollingsworth PJ, Geer JJ, Moises HC. Changes in alpha2 adrenoreceptors in various areas of the rat brain after long-term administration of "mu" and "kappa" opiate agonists. Life Sciences. 33: 369-72. PMID 6319892 DOI: 10.1016/0024-3205(83)90519-2  0.37
1983 Smith CB, Hollingsworth PJ, Garcia-Sevilla JA, Zis AP. Platelet alpha 2 adrenoreceptors are decreased in number after antidepressant therapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7: 241-7. PMID 6310693 DOI: 10.1016/0278-5846(83)90114-8  0.333
1983 Weiss RJ, Smith CB. Altered platelet alpha 2-adrenoceptors in patients with angina pectoris. Journal of the American College of Cardiology. 2: 631-7. PMID 6309938 DOI: 10.1016/S0735-1097(83)80302-7  0.351
1983 Weiss RJ, Tobes M, Wertz CE, Smith CB. Platelet alpha 2 adrenoreceptors in chronic congestive heart failure. The American Journal of Cardiology. 52: 101-5. PMID 6305182 DOI: 10.1016/0002-9149(83)90078-4  0.364
1983 Smith CB, Zelnik TC. Alpha-2 adrenergic receptors and the mechanism of action of antidepressants Behavioral and Brain Sciences. 6: 559. DOI: 10.1017/S0140525X00017477  0.32
1981 Crews FT, Smith CB. The effects of antidepressants on the retention and metabolism of [3H]-norepinephrine in rat brain slices. Neuropharmacology. 20: 363-9. PMID 7290350 DOI: 10.1016/0028-3908(81)90010-1  0.507
1981 García-Sevilla JA, Zis AP, Hollingsworth PJ, Greden JF, Smith CB. Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Archives of General Psychiatry. 38: 1327-33. PMID 6274267 DOI: 10.1001/Archpsyc.1981.01780370029003  0.343
1981 Smith CB, Garcia-Sevilla JA, Hollingsworth PJ. alpha 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment. Brain Research. 210: 413-8. PMID 6261876 DOI: 10.1016/0006-8993(81)90919-7  0.368
1981 Rarey KE, Ross MD, Smith CB. Quantitative evidence for cochlear, non-neuronal norepinephrine. Hearing Research. 5: 101-8. PMID 6172411 DOI: 10.1016/0378-5955(81)90029-0  0.307
1980 Crews FT, Smith CB. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration. The Journal of Pharmacology and Experimental Therapeutics. 215: 143-9. PMID 6256516  0.522
1979 Valentino RJ, Smith CB, Woods JH. An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum. Nature. 281: 370-2. PMID 225676 DOI: 10.1038/281370A0  0.316
1978 Crews FT, Smith CB. Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science (New York, N.Y.). 202: 322-4. PMID 211589 DOI: 10.1126/Science.211589  0.544
1974 Van Orden LS, Schaefer JM, Antonaccio MJ, Smith CB. Fine structural identification of a reserpine-resistant norepinephrine store in adrenergic nerve terminals in guinea-pig atria. The Journal of Pharmacology and Experimental Therapeutics. 188: 668-75. PMID 4131521  0.655
1966 Smith CB, Trendelenburg U, Langer SZ, Tsai TH. The relation of retention of norepineephrine-H3 to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. The Journal of Pharmacology and Experimental Therapeutics. 151: 87-94. PMID 5902183  0.557
1962 SMITH CB, DEWS PB. Antagonism of locomotor suppressant effects of reserpine in mice. Psychopharmacologia. 3: 55-9. PMID 13914163 DOI: 10.1007/BF00413107  0.475
Show low-probability matches.